Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study (VIDEO-NET)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02147106|
Recruitment Status : Completed
First Posted : May 26, 2014
Last Update Posted : May 5, 2017
Rationale: Patients with neuroendocrine tumors (NET) have a rare disease. Due to treating patients with a neuroendocrine tumor in 'NET knowledge centers' patients often have to travel long distances for follow-up visits at the outpatient clinic. Patients whose medical condition allows videoconsultation could save time by replacing outpatient clinic visits through videoconsultation for receiving follow-up care. Therefore, in this study we aim to introduce videoconsultation as a alternative for follow-up outpatient clinic visits in NET patients.
Objective: The primary objective is to assess if use of videoconsultation in follow-up care for NET patients is feasible. We hypothesize that videoconsultation is a suitable medium for providing follow-up care in NET patients. Secondary objectives are to explore the amount of time videoconsultation takes in comparison with outpatient clinic visits and the acceptability and satisfaction of physicians and patients with using videoconsultation in follow-up care.
Study design: The present study is a single-centre prospective feasibility study.
Study population: Adult NET patients under surveillance or treatment of the department Medical Oncology at the University Medical Centre Groningen (UMCG) whose medical condition allows videoconsultation will be invited to participate.
Intervention: Patient who give informed consent will participate in the study. Participants will receive follow-up care through videoconsultation instead of conventional visits at the outpatient clinic.
Main study parameters/endpoints: The main endpoint is the feasibility of videoconsultation for follow-up care in NET patients. We hypothesize that videoconsultation is a suitable medium for providing follow-up care.
|Condition or disease||Intervention/treatment|
|Neuroendocrine Tumor||Other: Videoconsultation|
|Study Type :||Observational|
|Actual Enrollment :||26 participants|
|Official Title:||Use of Video Consultation in Follow-up Care for Patients With a NeuroEndocrine Tumor: a Feasibility Study (VIDEO-NET Study)|
|Study Start Date :||May 2014|
|Actual Primary Completion Date :||March 2017|
|Actual Study Completion Date :||March 2017|
Performing two videoconsulations with the treating medical oncologist
- Feasibility [ Time Frame: 1 year ]Participation rates, reason for declining participation, number of completed videoconsultations, dropout rate and reason for dropout will be noted in study records to evaluate feasibility of videoconsultation
- Amount of time [ Time Frame: 1 year ]The amount of time NET patients are spending with videoconsultation in comparison with conventional outpatient clinic visits.
- Acceptability and satisfaction of patients [ Time Frame: 1 year ]The acceptability and satisfaction of patients with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.
- Acceptability and satisfaction of physicians [ Time Frame: 1 year ]The acceptability and satisfaction of physicians with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02147106
|University Medical Center Groningen|
|Groningen, Netherlands, 9713 GZ|
|Principal Investigator:||A.M.E. Walenkamp, MD PhD||University Medical Center Groningen|